IPO market unfriendly indeed. I note the underwriters are not even close to putting numbers into the Bruker AXS S-1. Well, that at least reduces the research burdens here at BLUE HP . . .
>>MOUNTAIN VIEW, Calif., Dec. 10 /PRNewswire/ -- Caliper Technologies Corp. (Nasdaq: CALP - news) and Wako Pure Chemical Industries, Ltd. of Japan have formed an exclusive agreement providing Wako with rights to distribute the Caliper 250 High Throughput Screening (HTS) system and chips in Japan. Caliper Technologies develops and manufactures LabChip® systems and sells them in the U.S. through the company's own direct domestic sales organization. The agreement with Wako represents Caliper's first HTS product marketing endeavor in Japan.
The Caliper 250 HTS system miniaturizes, integrates and automates high-throughput screening, the process of testing each component of large chemical compound libraries to discover and characterize compounds with specific biochemical activities. Pharmaceutical companies use high-throughput screening assays to uncover compounds of potential therapeutic value. A single high-throughput-screening project might require critical laboratory analysis of hundreds of thousands of individual chemical compounds. By performing high-throughput screening on a small chip as part of an automated workflow, the Caliper 250 HTS system speeds up the assay development process, improves data quality and reproducibility, and reduces reagent and sample usage.
Through well-established relationships with leading Japanese pharmaceutical companies, Wako offers market access, leadership and reach to promote Caliper's HTS systems in Japan. Wako is a major supplier of specialty chemicals, clinical diagnostics, and biological products for Japanese biotech research. For more information, please visit Wako's web site at wako-chem.co.jp .<<
snip
Cheers, Tuck |
